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Lyssavirus surveillance in bats was performed in
Bangladesh during 2003 and 2004. No virus isolates were
obtained. Three serum samples (all from Pteropus gigan-
teus, n = 127) of 288 total serum samples, obtained from
bats in 9 different taxa, neutralized lyssaviruses Aravan and
Khujand. The infection occurs in bats in Bangladesh, but
virus prevalence appears low.
B
ats are known reservoirs of viruses in the Lyssavirus
genus, family Rhabdoviridae. In the Americas, bats
maintain the circulation of different lineages of rabies
virus (RABV, genotype 1) (1). Lagos bat virus (genotype
2) and Duvenhage virus (DUVV, genotype 4) were isolat-
ed from bats in Africa (2). European bat lyssaviruses, types
1 and 2 (EBLV-1 and EBLV-2, genotypes 5 and 6, respec-
tively) circulate in European bat populations (3). West
Caucasian bat virus, a new putative lyssavirus genotype,
was recently isolated from a bat in southern Europe (4).
Australian bat lyssavirus (ABLV, genotype 7) was isolated
from different genera of Australian bats (5).
Data on rabies in Asian bats are limited because of a
lack of a suitable surveillance system. Only a few investi-
gators reported presumable RABV isolates of bat origin in
India and Thailand, but these were not corroborated, nor
were reports about bat rabies in Siberia and Uzbekistan
(6). No confirmed genotype 1 lyssavirus isolates are avail-
able from bats outside the Americas, to date. Recently, 3
lyssaviruses (Aravan, Khujand [6], and Irkut [4] viruses)
were isolated from bats in different locations of Asia.
These representatives were suggested as 3 new putative
genotypes of the Lyssavirus genus, according to their
genetic properties. Moreover, antibodies to lyssaviruses
have been demonstrated in serum specimens of bats from
the Philippines, Cambodia, and Thailand (7–9). In this arti-
cle, we extend information on the geographic distribution
of rabies among Asian bats and describe a limited survey
in Bangladesh for evidence of lyssavirus activity.
The Study
This project began as part of a larger study concerned
with a suspected Nipah virus outbreak in the region. Active
surveillance of bats was performed in 3 districts of
Bangladesh: Meherpur and Naogaon during March 2003
and Rajbari during February and March 2004 (Figure 1).
The animals were collected randomly from different
roosts, trees, and fruit plantations.
Bats were anesthetized by a 0.05- to 0.1-mg intramus-
cular injection of ketamine hydrochloride. Injured bats and
those that had clinical signs and symptoms were eutha-
nized under sedation by exsanguination. Blood was trans-
ferred to serum separator tubes and was refrigerated until
centrifugation. Serum was decanted into individual screw-
topped vials. When possible, bats were identified to
species. Brains of all euthanized bats were removed at
necropsy and placed into individual sterile containers.
Additional organs and oral swabs were also obtained from
each bat. All specimens were held in temporary storage at
–18°C (after collection) and later placed at –80°C.
Carcasses of representative specimens were placed in for-
malin for archival purposes.
Bat brains collected in 2003 (N = 212, Table) were test-
ed by the direct fluorescent-antibody test (DFAT) (10), by
using both monoclonal (Centocor Inc., Malvern, PA, USA)
and polyclonal (Chemicon International, Temecula, CA,
USA) fluorescein isothiocyanate–labeled anti–rabies virus
antibodies, and were subsequently processed for isolation
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Figure 1. Map of Bangladesh with bat surveillance regions indi-
cated (circles). by the mouse inoculation test (MIT) (11). If death occurred
during the MIT, mouse brains were subjected to the DFAT,
and a second intracerebral passage was conducted with 5%
brain suspensions, using 0.22-µm filters (Millipore Corp.,
Bedford, MA, USA). Bat brains collected in 2004 (N =
151, Table) were subjected to the DFAT only.
The presence of virus-neutralizing antibodies was
determined by an adaptation of the rapid fluorescent focus
inhibition test (RFFIT), as described (7). Because of vol-
ume limitations and the cytotoxicity of some specimens,
207 serum samples were available for testing at a starting
dilution of 1:20, and 81 samples at a starting dilution of
1:50 (Table). Four different lyssaviruses were used in an
initial in vitro screening: Aravan, Khujand, Irkut, and
ABLV. When a positive result was obtained, testing on the
sample was repeated, and comparative assays undertaken
for additional lyssaviruses: EBLV-1, EBLV-2, DUVV, and
RABV (e.g., routine rabies challenge virus standard, CVS-
11). The dose of each virus used for the RFFIT was ≈50
infectious units per 100 µL. The duration of the test was 20
hours for ABLV and CVS-11 and 40 hours for other chal-
lenge viruses.
No evidence of lyssavirus antigen was detected in any
bat brain by DFAT, and no neurotropic viruses were isolat-
ed by mouse inoculation. If a limited number of deaths
occurred during the initial MIT (1 or 2 mice of 5 infected),
those effects were not reproduced during the subpassage
by filtration, which suggests that bacterial contamination
of the field samples caused the death of mice during the
initial MIT.
One serum sample repeatedly demonstrated neutraliz-
ing activity against Khujand virus, at a titer of 54. This
sample was obtained from a young female giant Indian fly-
ing fox (Pteropus giganteus) (Figure 2) captured in the
Meherpur District in 2003. Two other serum samples
obtained from the same species (1 male and 1 female) in
Rajbari District in 2004, neutralized Aravan and Khujand
viruses at titers of 14–16. For these latter samples, neutral-
ization was detected at dilutions of 1:20 and 1:25 but not
detected at a dilution of 1:50. The titers of all serum spec-
imens were <10 (i.e., no neutralization occurred in the
dilution of 1:20) against other lyssaviruses.
Conclusions
We have presented serologic evidence of lyssavirus
infection in bats from Bangladesh. Antigenic cross-reactiv-
ity has been reported among Aravan, Khujand, and other
members of the Lyssavirus genus (12). Therefore,
detectable antibody may cross-react with other related
lyssaviruses, as well as with viruses yet to be discovered.
Based upon this preliminary survey, a low prevalence
of lyssavirus infection appears in P. giganteus in
Bangladesh. Thus, it is not surprising that all brain samples
collected were negative for detection of lyssavirus antigen.
Because different lyssaviruses and bat species are found in
Asia, and therefore different virus-host interactions would
be expected in the region, extrapolating antibody-posi-
tive/virus-positive ratios, as have been estimated from
American (13,14) or European (15) bat populations, would
be difficult.
Further surveillance for Asian bat lyssaviruses should
be conducted. Public health authorities need to be aware of
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Figure 2. Giant Indian flying foxes (Pteropus giganteus). (Photo by
I.V. Kuzmin.)the potential for bats to transmit lyssaviruses, and public
education of this potential should be enhanced.
Frugivorous bats forage in fruit plantations in many
regions of the Old World tropics, including Bangladesh.
Indigenous people capture and may consume these ani-
mals. Direct contact between humans and bats frequently
occurs during these interactions. Absence of current infor-
mation on human rabies after bat exposure may be a result
of inadequate education, incomplete surveillance, and lack
of characterization of viruses from rabies cases (6).
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